Phase II Study of 5-Fluorouracil, Oxaliplatin Plus Dasatinib in First-line Metastatic Pancreatic Adenocarcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Dasatinib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 21 Jun 2017 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.
- 21 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 21 Jun 2017 Status changed from recruiting to active, no longer recruiting.